Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1700 Records) |
Query Trace: CYP2D6[original query] |
---|
Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine. Journal of clinical pharmacology 2023 12 . Zhipeng Wang, Yuan Gao, Xingfang Ji, Tong Wu, Libin Pu, Wen Q |
Novel independent trans- and cis-genetic variants associated with CYP2D6 expression and activity in human livers. Drug metabolism and disposition: the biological fate of chemicals 2023 12 . Dylan Smith, Bing He, Jian Shi, Hao-Jie Zhu, Xinwen Wa |
[Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study]. Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13. P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev |
Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi Long-Read and Illumina Short-Read Sequencing. Journal of personalized medicine 2023 12 13 (12): . David Barthélémy, Elodie Belmonte, Laurie Di Pilla, Claire Bardel, Eve Duport, Veronique Gautier, Léa Pay |
Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias. Medicina (Kaunas, Lithuania) 2023 12 59 (12): . Ewa Moric-Janiszewska, S?awomir Smolik, Les?aw Szyd?owski, Ma?gorzata Kapr |
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study. Biomedicines 2023 12 11 (12): . Mahmood Mahajna, Rami Abu Fanne, Matitiahu Berkovitch, Elias Tannous, Shlomo Vinker, Ilan Green, Ilan Mat |
The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism. Biochemical genetics 2023 12 . Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ayman Shawqi Alhazmi, Samah Fathy Ibrahim, Fawwaz Abdul Razaq Al Enazi, Ezzeldeen Hasan Ghanem, Adel Mohammed Binduraih |
No drug-drug interactions between selective prolyl-trna synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants. Clinical and translational science 2023 12 . Wonsuk Shin, Min Young Park, Jongwoo Kim, Jihyeon Kim, Jun Hee Nam, Jongwon Choi, A-Young Yang, Hyounggyoon Yoo, Yil-Seob Lee, Anhye K |
Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis. Psychopharmacology bulletin 2023 12 53 (4): 15-22. A A Parkhomenko, M S Zastrozhin, VYu Skryabin, A E Petukhov, S A Pozdniakov, V A Ivanchenko, I A Zaytsev, I V Bure, P O Bochkov, K A Akmalova, V V Smirnov, E A Bryun, D A Sych |
Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions. Neurogastroenterology and motility 2023 12 e14722. Revati Varma, Jeffrey P Staab, Eric T Matey, Jessica A Wright, Brototo Deb, Konstantinos N Lazaridis, Lawrence A Szarka, Kent R Bailey, Adil E Bharuc |
Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone. Pain reports 2023 11 8 (6): e1113. Samina Ali, Aran Yukseloglu, Colin J Ross, Rhonda J Rosychuk, Amy L Drendel, Robin Manaloor, David W Johnson, Sylvie Le May, Bruce Carlet |
Screening, Confirmation and Validation of Mismatch AS F-Primers for Hypertension-Related Genotyping. Studies in health technology and informatics 2023 11 308 359-364. Ping Yang, Wei Lan, Quanlin Su, Chunyan Li, Jie Zheng, Jing Zhang, Yue Hu, Wenjun L |
Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study. BMC pharmacology & toxicology 2023 11 24 (1): 64. Jing Yang, Ying-Zi Sun, Qun-Fang Li, Zheng Fu, Yu-Yao Guan, Chao Song, Lei Zhe |
Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE. Lupus science & medicine 2023 11 10 (2): . Han Xie, Xin Wen, Yuchun Wang, Xuan Huang, Qing Shu, Dandan Wang, Linyu Geng, Ziyi Jin, Wei Shen, Weihong Ge, Yizhun Zhu, Lingyun S |
Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of pharmaceutical and biomedical analysis 2023 11 238 115839. Fatemeh Saghafi, Ebrahim Salehifar, Pouneh Ebrahimi, Mohammad Reza Shiran, Ehsan Zaboli, Seyed Mojtaba Sohrevardi, Tannaz Jamialahmadi, Adeleh Sahebnasagh, Amirhossein Sahebk |
Nutrimetric validation of solanidine as dietary-derived CYP2D6 activity marker in vivo. Clinical pharmacology and therapeutics 2023 11 . Julian Peter Müller, Jens Sarömba, Patrick Ziegler, Roman Tremmel, Jens Rengelshausen, Elke Schaeffeler, Katja S Just, Matthias Schwab, Thomas Kraus, Julia C Stin |
Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics. Therapeutic advances in rare disease 2023 11 4 26330040231204643. Stephanie Feleus, Maaike van der Lee, Jesse J Swen, Raymund A C Roos, Susanne T de B |
Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine. Heliyon 2024 4 10 (7): e28832. Ye Yang, Wenqing Liu, Renrong |
Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical pharmacology and therapeutics 2024 4 . Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, Andre Franke, Ingolf Cascor |
Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug. The pharmacogenomics journal 2024 4 24 (3): 13. Jianchang Qian, Tao Xu, Peipei Pan, Wei Sun, Guoxin Hu, Jianping C |
Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. Minerva anestesiologica 2024 4 . Mónica Escorial, Javier Muriel, Laura Agulló, Thomas Zandonai, César Margarit, Domingo Morales, Ana M Pei |
Impact of Viloxazine Extended-Release Capsules (Qelbree) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical drug investigation 2024 4 . Zhao Wang, Tesfaye Liranso, Zulane Maldonado-Cruz, Alisa R Kosheleff, Azmi Nass |
The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations. Cancer chemotherapy and pharmacology 2024 2 . Xiaoya Ma, Yujie Li, Xufeng Zang, Jinping Guo, Wenqian Zhou, Junhui Han, Jing Liang, Panpan Wan, Hua Yang, Tianbo J |
Comprehensive analysis of the role of cuproptosis-related genes in the prognosis and immune infiltration of adrenocortical Carcinoma. Heliyon 2024 1 10 (1): e23661. Zhiyuan You, Jiqing He, Zhongming G |
An increase in urinary primaquine and a reduction in urinary primaquine-5,6-orthoquinone in the Thai population with CYP2D6 reduced enzyme function. Heliyon 2024 1 10 (2): e24351. Waritda Pookmanee, Siriwan Thongthip, Mathirut Mungthin, Chonlaphat Sukasem, Jeeranut Tankanitlert, Pajaree Chariyavilaskul, Supeecha Wittayalertpan |
Genetic prediction of antihyperglycemic drug targets and risk of epilepsy: a mendelian randomisation study. BMC pharmacology & toxicology 2024 1 25 (1): 1. Kaiping Zhou, Huan Yang, Zhihao Xie, Weiping Wang, Zhenzhen |
A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential 'culprit' for the tramadol 'abuse crisis'. BMC medical genomics 2024 1 17 (1): 28. Nicholas Ekow Thomford, Susanna Aba Abraham, Samuel Badu Nyarko, Robert Peter Bin |
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders. The Journal of clinical psychiatry 2024 1 85 (1): . Amanda Holck, Marie Asp, Henrik Green, Åsa Westrin, Margareta Re |
Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients. BMC psychiatry 2024 1 24 (1): 41. Xiaoyi Wang, Jing Huang, Jianjun Lu, Xuemei Li, Hui Tang, Ping Sh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: